RESEARCH-USE BIOSIMILAR ANTIBODY
Erenumab
Monoclonal antibody · IgG2
Erenumab (AMG-334) is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab prevents the increase in dermal blood flow in cynomolgus monkeys. Erenumab can be used in the research of episodic migraine.
TARGETCALCRL
YMonoclonal antibody
CATALOGSC-BS-569
CATALOG NUMBERSC-BS-569
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Erenumab (AMG-334) is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab prevents the increase in dermal blood flow in cynomolgus monkeys. Erenumab can be used in the research of episodic migraine.
Erenumab is a recombinant research-use antibody directed against CALCRL.